| Genetic evolution and tropism of transmissible gastroenteritis coronaviruses CM Sánchez, F Gebauer, C Suñé, A Mendez, J Dopazo, L Enjuanes Virology 190 (1), 92-105, 1992 | 218 | 1992 |
| Antigenic homology among coronaviruses related to transmissible gastroenteritis virus CM Sánchez, G Jiménez, MD Laviada, I Correa, C Suñé, MJ Bullido, ... Virology 174 (2), 410-417, 1990 | 203 | 1990 |
| Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus I Correa, G Jiménez, C Suñé, MJ Bullido, L Enjuanes Virus Research 10 (1), 77-93, 1988 | 119 | 1988 |
| CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription C Suñé, T Hayashi, Y Liu, WS Lane, RA Young, MA Garcia-Blanco Molecular and cellular biology 17 (10), 6029-6039, 1997 | 118 | 1997 |
| Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat C Suñé, MA García-Blanco Journal of virology 69 (10), 6572-6576, 1995 | 115 | 1995 |
| Functional coupling of transcription and splicing M Montes, S Becerra, M Sánchez-Álvarez, C Suñé Gene 501 (2), 104-117, 2012 | 98 | 2012 |
| Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus I Correa, F Gebauer, MJ Bullido, C Suǹí, MFD Baay, KA Zwaagstra, ... Journal of General Virology 71 (2), 271-279, 1990 | 91 | 1990 |
| Membrane protein molecules of transmissible gastroenteritis coronavirus also expose the carboxy-terminal region on the external surface of the virion C Risco, IM Antón, C Suñé, AM Pedregosa, JM Martin-Alonso, F Parra, ... Journal of virology 69 (9), 5269-5277, 1995 | 90 | 1995 |
| Mechanisms of transmissible gastroenteritis coronavirus neutralization C Suñé, G Jiménez, I Correa, MJ Bullido, F Gebauer, C Smerdou, ... Virology 177 (2), 559-569, 1990 | 76 | 1990 |
| Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure A Holguín, C Suñe, F Hamy, V Soriano, T Klimkait Journal of Clinical Virology 36 (4), 264-271, 2006 | 74 | 2006 |
| Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner C Suñé, MA Garcia-Blanco Molecular and cellular biology 19 (7), 4719-4728, 1999 | 72 | 1999 |
| Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its … M Sánchez-Álvarez, AC Goldstrohm, MA Garcia-Blanco, C Suñé Molecular and cellular biology 26 (13), 4998-5014, 2006 | 71 | 2006 |
| DNA delivery via cationic solid lipid nanoparticles (SLNs) C Carrillo, N Sánchez-Hernández, E García-Montoya, P Pérez-Lozano, ... European journal of pharmaceutical sciences 49 (2), 157-165, 2013 | 66 | 2013 |
| TCERG1 Regulates Alternative Splicing of the Bcl-x Gene by Modulating the Rate of RNA Polymerase II Transcription M Montes, A Cloutier, N Sánchez-Hernández, L Michelle, B Lemieux, ... Molecular and cellular biology 32 (4), 751-762, 2012 | 66 | 2012 |
| Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1 J Zhou, Y Liu, W Zhang, VM Popov, M Wang, N Pattabiraman, C Suñé, ... Journal of biological chemistry 285 (51), 40342-40350, 2010 | 63 | 2010 |
| Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein JM Torres, C SÁNCHEZ, C SUÑÉ, C SMERDOU, L PREVEC, F GRAHAM, ... Virology 213 (2), 503-516, 1995 | 53 | 1995 |
| Targeting splicing in the treatment of human disease M Suñé-Pou, S Prieto-Sánchez, S Boyero-Corral, C Moreno-Castro, ... Genes 8 (3), 87, 2017 | 51 | 2017 |
| A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral … IM Antón, C Suñé, RH Meloen, F Borrás-Cuesta, L Enjuanes Virology 212 (2), 746-751, 1995 | 48 | 1995 |
| Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors C Suñé, MA García-Blanco Journal of virology 69 (5), 3098-3107, 1995 | 47 | 1995 |
| A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid A Fàbregas, N Sánchez-Hernández, JR Ticó, E García-Montoya, ... International journal of pharmaceutics 473 (1-2), 270-279, 2014 | 44 | 2014 |
